TCR2 Therapeutics Inc. Free Cash Flow 2019-2023 | TCRR
TCR2 Therapeutics Inc. free cash flow from 2019 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| TCR2 Therapeutics Inc. Annual Free Cash Flow |
| 2022 |
-116.58 |
| 2021 |
-92.70 |
| 2020 |
-63.90 |
| 2019 |
-45.24 |
| 2018 |
-19.76 |
| 2017 |
-12.40 |
| 2016 |
-10.25 |
| TCR2 Therapeutics Inc. Quarterly Free Cash Flow |
| 2023-03-31 |
-39.63 |
| 2022-12-31 |
-116.58 |
| 2022-09-30 |
-89.19 |
| 2022-06-30 |
-58.56 |
| 2022-03-31 |
-33.05 |
| 2021-12-31 |
-92.70 |
| 2021-09-30 |
-62.68 |
| 2021-06-30 |
-41.13 |
| 2021-03-31 |
-25.42 |
| 2020-12-31 |
-63.90 |
| 2020-09-30 |
-45.76 |
| 2020-06-30 |
-33.65 |
| 2020-03-31 |
-16.91 |
| 2019-12-31 |
-45.24 |
| 2019-09-30 |
-34.11 |
| 2019-06-30 |
-21.93 |
| 2019-03-31 |
-11.02 |
| 2018-12-31 |
-19.76 |
| 2018-09-30 |
-13.25 |
| 2018-06-30 |
-8.47 |
| 2018-03-31 |
-3.38 |
